1. Factors associated with complex oral treatment device usage in patients with head and neck cancer
- Author
-
Stephen Palasi, Ning Zhang, Mikaela Bankston, Joy Godby, Hannah Burrows, Jennifer Lagunas, William Perkison, Brandon Gunn, Mark S. Chambers, David I. Rosenthal, William Morrison, Adam Garden, Clifton David Fuller, Sharon Giordano, and Eugene J. Koay
- Subjects
Stent ,SEER-Medicare ,Oral mucositis ,Head and neck cancer ,Radiation ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Purpose: The objective was to identify clinical and epidemiological factors associated with utilization of a complex oral treatment device (COTD), which may decrease toxicity in patients undergoing radiation therapy for head and neck cancer (HNC). Materials and Methods: We retrospectively reviewed data from 1992 to 2013 in the Surveillance, Epidemiology, and End Results (SEER)-Medicare databases to analyze COTD usage during intensity-modulated radiation therapy (IMRT) for patients diagnosed with cancer of the tongue, floor of mouth, nasopharynx, tonsil, or oropharynx. Patients with a radiation simulation and complex treatment device code within 4 weeks before the first IMRT claim were identified as meeting COTD usage criteria. Demographic, regional, tumor, and treatment data were analyzed. Results: Out of 4511 patients who met eligibility criteria, 1932 patients (42.8%) did not utilize a COTD while 2579 (57.2%) met usage criteria. COTD utilization increased over time (36.36% usage in 1992 vs. 67.44% usage in 2013, p
- Published
- 2021
- Full Text
- View/download PDF